Introduction
Pneumonia is the leading cause of post-neonatal deaths in children younger than 5 years, with many of the deaths occurring in low-and middle-income countries. 1, 2 Several interventions exist that prevent pneumonia, 3 including the pneumococcal conjugate vaccine; however, this vaccine is relatively expensive, meaning that governments require evidence of its health benefits in routine use. Such evidence is often provided by hospital admission data, but this requires a standardized pneumonia case definition as well as uniform admission criteria for pneumonia. To improve the case management of pneumonia in low-and middle-income countries, the World Health Organization (WHO) developed the Integrated Management of Childhood Illness guidelines in 1995.
In 2005, these guidelines 4 defined severe pneumonia as the presence of cough or difficulty in breathing and tachypnoea (> 50 breaths per minute for children aged 2-11 months and > 40 breaths per minute for children aged 12-59 months) plus lower chest indrawing, and one or more of the general danger signs, which include: an inability to drink; persistent vomiting; convulsions; lethargy; unconsciousness; stridor in a calm child; severe malnutrition (as documented in the medical records); central cyanosis; or a saturation of oxygen of < 90% in room air. Many low-and middle-income countries adopted these criteria. However, equivalence and non-inferiority studies found no difference in treatment failure rates between patients with pneumonia with lower chest indrawing who were treated with parenteral antibiotics in hospital, and outpatient treatment with oral antibiotics. 5, 6 As a result, WHO modified the classification of pneumonia severity; 7 the 2013 definition of severe pneumonia requiring hospital admission is the presence of cough or difficulty in breathing and tachypnoea, plus one or more of the general danger signs, but not lower chest indrawing.
Between 2010 and 2013, before WHO's case definition for severe pneumonia was revised, more than 54 countries, supported by Gavi, the Vaccine Alliance, implemented the pneumococcal conjugate vaccine. 8 The impact of this change in case definition on the documented burden of severe pneumonia is unclear.
We therefore assess clinical data describing pneumonia hospitalizations in six countries and determine the effect of the revised 2013 WHO definition of severe pneumonia on the proportion of all-cause hospitalized pneumonia cases that are classified as severe, and on the incidence of severe hos-Impact of the change in WHO's severe pneumonia case definition on hospitalized pneumonia epidemiology: case studies from six countries Fiona pitalized pneumonia. We also explore the impact of this change in the case definition on radiological pneumonia, that is, patients with primary end-point consolidation evident from chest X-ray. Using observational data from seven sites, two from the African Region and five from the Western Pacific Region, we describe the epidemiology of severe pneumonia using both the 2005 and 2013 WHO definitions. We quantify the apparent reduction of hospitalized pneumonia cases with severe pneumonia, as well as the apparent fall in annual incidence of severe pneumonia hospitalizations with primary endpoint consolidation, resulting directly from the change in definition of severe pneumonia.
Methods

Data sources
We requested data from investigators undertaking retrospective or prospective hospitalized pneumonia studies in children aged 2-23 months from seven sites in six countries before the introduction of the pneumococcal conjugate vaccine: Fiji, Gambia, 9 Lao People's Democratic Republic, Malawi, [10] [11] [12] Mongolia and Viet Nam (with separate data sets for Hanoi and Ho Chi Minh City; Table 1 ). We reviewed the individual medical records of patients from all sites and extracted clinical information, including: age, respiratory rate and the presence of lower chest wall indrawing, stridor when calm or any general danger signs (inability to drink or vomiting everything, convulsions, lethargy or unconsciousness). Further details on the data collection methods at each study site are available from the corresponding author.
Data processing
We used the extracted clinical information to classify pneumonia cases as severe according to the 2005 and 2013 WHO definitions of severe pneumonia and calculated the median age (in months) and interquartile range of patients for each site. We compared the different median ages of the children with severe pneumonia according to the different definitions using the non-parametric K-sample test on the equality of medians. We also calculated the percentage of all-cause pneumonia hospitalizations with lower chest wall indrawing.
For those sites at which radiography data were collected (Fiji, Gambia, Mongolia and Viet Nam), an experienced radiologist, blind to the clinical findings, reinterpreted all chest radiographs to determine the presence of primary endpoint pneumonia according to WHO criteria. 14, 15 Where population data and a defined catchment population were available (Fiji, Gambia, Mongolia and Ho Chi Minh City in Viet Nam), annual incidence rates with 95% confidence intervals (CI) of hospitalizations from severe pneumonia according to both definitions, as well as the incidence of patients with primary end-point consolidation, were calculated per 100 000 infants aged 2-23 months. The differences in these incidence rates, with 95% CIs, were calculated using standard errors where appropriate.
We conducted all statistical analyses using the software Stata, version 14.0 (StataCorp. LLC, College Station, United States of America).
Results
Our analysis of the impact of the change in definition of severe pneumonia included 24 287 pneumonia hospitalizations of children aged 2-23 months ( Table 1 ). The median ages of hospitalized pneumonia patients with severe pneumonia according to either the 2005 or 2013 definition ranged from 5 months in Hanoi to 12 months in Mongolia, and did not differ significantly by pneumonia case definition at each site (all P > 0.05; Table 2 ).
The percentage of all-cause pneumonia hospitalizations with lower 
Discussion
We have shown that, in six out of seven sites from the African and Western Pacific Regions, the percentage of pneumonia hospitalizations in children aged 2-23 months with severe pneumonia was significantly less using the 2013 definition of severe pneumonia compared with the 2005 definition. Similarly, at sites where incidence could be calculated, we have demonstrated that the annual incidence of pneumonia hospitalizations with severe pneumonia was significantly less using the 2013 definition of severe pneumonia compared with the 2005 definition. These findings are not unexpected given that the presence of lower chest wall indrawing (without danger signs) is no longer included in the 2013 WHO case definition for severe pneumonia; 8 we calculated that 64.5 to 97.4% of hospitalized pneumonia cases had lower chest wall indrawing.
An unpublished review (Nordgren M, GSK Vaccines, personal communication, 2016) of studies assessing the impact of the pneumococcal conjugate vaccine on pneumonia burden in infants younger than 2 years found much variability. These studies were observational or double-blinded randomized controlled trials, using the case definitions all-cause pneumonia, WHO-defined pneumonia (year not specified) and pneumococcal pneumonia. The varying sensitivity and specificity of the different case definitions 9, 16, 17 mean that the magnitude of the impact of the vaccine on pneumonia calculated from studies of different design and using different case definitions cannot be directly compared.
Primary end-point consolidation has moderate sensitivity and specificity, and is the end-point which has shown reasonable consistency within clinical trials. 18, 19 However, in low-and middle-income countries, whether an infant receives a chest radiograph is often determined by clinical severity; those with danger signs (and not lower chest wall indrawing) are more likely to receive a radiograph compared with those without, irrespective of which WHO severe pneumonia definition is used. Unfortunately, we were unable to compare the percentage of pneumonia hospitalizations with danger signs, as each site used slightly different definitions of danger signs. This may explain why our findings show that, within each site, the changes to the definition of severe pneumonia had no significant effect on the percentage of severe pneumonia hospitalizations with radiological pneumonia. However, the incidence of pneumonia hospitalizations with primary end-point consolidation was significantly different, depending on the definition of severe pneumonia, within three of the four sites for which data were available.
Unsurprisingly, we observed variability in the incidence of pneumonia hospitalizations with severe pneumonia between sites, regardless of the case definition used. The incidence of hospitalized pneumonia is affected by many factors, including income, comorbidities and exposure to air pollution; 20, 21 variability between countries in hospitalized pneumonia burden is therefore to be expected. In addition, the incidence of pneumonia hospi- talizations with severe pneumonia is also influenced by access to care and admission criteria. 22 For example, despite being tertiary facilities, both Vietnamese sites had a lower percentage of pneumonia admissions that were severe according to the 2005 definition than compared with other sites, indicating a lower threshold for admission and/ or better health-seeking behaviour. A recent study has reported that many children with non-severe respiratory disease are admitted to primary, secondary and tertiary care facilities in Viet Nam. 23 We found that the presence of lower chest wall indrawing varied between the two Vietnamese sites, suggesting that the admission criteria also vary between these hospitals. Furthermore, the diagnosis of lower chest wall indrawing is observer dependent, also affecting within-site observations. 24 Although the presence of danger signs was not recorded consistently between the sites, the key clinical criteria of severe pneumonia using either the 2005 or 2013 severe pneumonia definition (age-specific respiratory rate, cough and presence of lower chest wall indrawing) were recorded consistently at each site, making within-site comparisons possible.
The change from the 2005 to 2013 severe pneumonia case definition aimed to simplify the pneumonia treatment algorithm for community health workers and reduce unnecessary burden on families and health-care services. 25 However, our findings need to be considered when discussing changes in the epidemiological impact on pneumonia burden and pneumonia impact evaluation. If clinicians have changed their admission criteria for pneumonia in accordance with changes in WHO guidelines, then the incidence of pneumonia hospitalizations will appear to decline regardless of any intervention, because of children with pneumonia and lower chest indrawing (no danger signs) now being managed as outpatients. For pneumonia epidemiology and pneumonia intervention evaluations, our findings highlight the importance of stating which WHO definition is used and whether admission criteria changed during the observation period. Further studies are also required to understand the impact of this definitional change in high-mortality settings, where rates of bacterial pneumonia are increased and lower chest wall indrawing has been identified as an independent risk factor for mortality. 26 
Резюме
Воздействие изменений в определении тяжелого случая пневмонии, согласно ВОЗ, на эпидемиологию госпитализированных больных с пневмонией: тематические исследования в шести странах Цель Количественная оценка воздействия изменений в определении тяжелой формы пневмонии на документированное бремя заболевания. Методы Авторы изучили имеющиеся данные, собранные во время обсервационных исследований пневмонии у госпитализированных больных до начала использования пневмококковой конъюгированной вакцины у детей в возрасте от 2 до 23 месяцев из Вьетнама, Гамбии, Лаосской Народно-Демократической Республики, Малави, Монголии и Фиджи. Клинические данные использовались для расчета процентной доли госпитализации пациентов с тяжелой формой пневмонии, независимо от ее причины, с консолидацией по основной конечной точке в соответствии с двумя разными определениями ВОЗ: от 2005 года и от 2013 года. При наличии популяционных данных авторы также рассчитывали частоту госпитализации пациентов с тяжелой формой пневмонии в соответствии с этими двумя определениями. Результаты В шести из семи исследованных стран доля госпитализации пациентов с тяжелой формой пневмонии, независимо от причины заболевания, была значительно ниже (P < 0,001) при использовании определения ВОЗ от 2013 года, чем при использовании определения от 2005 года. Однако процентная доля госпитализации с тяжелой формой пневмонии, согласно двум разным определениям такой тяжелой формы, с консолидацией по основной конечной точке мало различалась в разных странах. Ежегодная частота случаев госпитализации с тяжелой формой пневмонии на 100 000 младенцев была значительно ниже (все значения Вывод Пересмотр определений ВОЗ для тяжелой формы пневмонии влияет на эпидемиологию заболевания и, следовательно, на интерпретацию оценки воздействия любого вмешательства, связанного с этим заболеванием.
Resumen
Impacto del cambio en la definición de caso de neumonía grave de la OMS en la epidemiología de la neumonía hospitalizada: estudios de caso de seis países
Objetivo Cuantificar el impacto del cambio en la definición de neumonía grave sobre la carga de neumonía documentada. Métodos Se revisaron los datos existentes adquiridos durante los estudios observacionales de neumonía hospitalizada, antes de la introducción de la vacuna antineumocócica conjugada, en lactantes de 2 a 23 meses de edad procedentes de Fiji, Gambia, Malawi, Mongolia, la República Democrática Popular Lao y Vietnam. Se utilizaron datos clínicos para calcular el porcentaje de hospitalizaciones por neumonía de cualquier causa con neumonía grave, y con consolidación del punto final primario, de acuerdo con las definiciones de la Organización Mundial de la Salud (OMS) de 2005 o 2013. Cuando se dispuso de datos demográficos, también se calculó la incidencia de las hospitalizaciones por neumonía grave de acuerdo con las diferentes definiciones. Resultados En seis de los siete sitios, los porcentajes de hospitalizaciones por neumonía de cualquier causa con neumonía grave fueron significativamente menores (p < 0,001) según la definición de la OMS de 2013 en comparación con la de 2005. Sin embargo, el porcentaje de hospitalizaciones por neumonía grave, según las dos definiciones de neumonía grave, con consolidación del punto final primario varió poco dentro de cada sitio. La incidencia anual de hospitalizaciones por neumonía grave por cada 100.000 lactantes fue significativamente menor (total p < 0,001) según la definición de 2013 en comparación con la de 2005 y osciló entre una diferencia de −301,0 (intervalo de confianza, IC, del 95 %: −405,2 a −196,8) en Fiji y −3242,6 (IC del 95 %: −3695,2 a −2789,9) en Gambia. Conclusión La revisión de la definición de neumonía grave de la OMS afecta a la epidemiología de la neumonía y, por tanto, a la interpretación de cualquier evaluación del impacto de una intervención para la neumonía.
